Cargando…
PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design
BACKGROUND: Many adult congenital heart disease (ACHD) patients are at risk of sudden cardiac death (SCD). An implantable cardioverter-defibrillator (ICD) may prevent SCD, but the evidence for primary prevention indications is still unsatisfactory. STUDY DESIGN: PREVENTION-ACHD is a prospective stud...
Autores principales: | Vehmeijer, J. T., Koyak, Z., Zwinderman, A. H., Harris, L., Peinado, R., Oechslin, E. N., Silversides, C. K., Bouma, B. J., Budts, W., van Gelder, I. C., Oliver, J. M., Mulder, B. J. M., de Groot, J. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773785/ https://www.ncbi.nlm.nih.gov/pubmed/31270738 http://dx.doi.org/10.1007/s12471-019-1297-3 |
Ejemplares similares
-
The Decisions, Interventions, and Goals in ImplaNtable Cardioverter‐DefIbrillator TherapY (DIGNITY) Pilot Study
por: Kramer, Daniel B., et al.
Publicado: (2017) -
Effect of ElectroMagnetic interference from SmartPHone on cardiac ImplaNtable electronic device (EMI‐PHONE study)
por: Apakuppakul, Sanatcha, et al.
Publicado: (2022) -
Prolonged T(peak)‐T(end) interval is a risk factor for sudden cardiac death in adults with congenital heart disease
por: Vehmeijer, Jim T., et al.
Publicado: (2019) -
1158. Immunogenicity of COVID-19 vaccine four-dose series in healthy community dwelling adults 50 years and above: interim analysis from the ‘PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines’ (PREVENT-COVID) study
por: Gaultier, Gabrielle N, et al.
Publicado: (2023) -
THE IMPACT OF THE COVID-19 PANDEMIC RESTRICTIONS ON THE PROVISION OF ACHD CARE ACROSS CANADA
por: Mao, R., et al.
Publicado: (2022)